1. Home
  2. MPV vs BWAY Comparison

MPV vs BWAY Comparison

Compare MPV & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barings Participation Investors

MPV

Barings Participation Investors

HOLD

Current Price

$18.55

Market Cap

201.1M

Sector

Finance

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$17.15

Market Cap

337.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPV
BWAY
Founded
1988
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Finance Companies
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
201.1M
337.9M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
MPV
BWAY
Price
$18.55
$17.15
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$23.50
AVG Volume (30 Days)
25.2K
62.4K
Earning Date
01-01-0001
11-11-2025
Dividend Yield
8.71%
N/A
EPS Growth
N/A
213.09
EPS
1.71
0.13
Revenue
N/A
$49,094,000.00
Revenue This Year
N/A
$330.76
Revenue Next Year
N/A
$22.24
P/E Ratio
$9.35
$51.80
Revenue Growth
N/A
27.08
52 Week Low
$11.18
$7.84
52 Week High
$16.42
$18.18

Technical Indicators

Market Signals
Indicator
MPV
BWAY
Relative Strength Index (RSI) 33.34 54.19
Support Level $18.00 $15.97
Resistance Level $20.21 $17.38
Average True Range (ATR) 0.44 0.68
MACD -0.15 -0.10
Stochastic Oscillator 27.15 51.25

Price Performance

Historical Comparison
MPV
BWAY

About MPV Barings Participation Investors

Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: